Literature DB >> 33526847

Value of Patlak Ki images from 18F-FDG-PET/CT for evaluation of the relationships between disease activity and clinical events in cardiac sarcoidosis.

Masatoyo Nakajo1, Satoko Ojima2, Hirofumi Kawakami3, Atsushi Tani4, Akira Hirayama3, Megumi Jinguji4, Takuro Kubozono2, Mitsuru Ohishi2, Takashi Yoshiura4.   

Abstract

The association between 18F-fluorodeoxyglucose (18F-FDG) myocardial uptake and clinical presentations in cardiac sarcoidosis (CS) has not yet been clarified. The Patlak slope, Ki, which represents the rate of 18F-FDG uptake is a quantitative index of 18F-FDG metabolism. This study aims to investigate the usefulness of standardized uptake value (SUV) and Patlak Ki images (Ki images) extracted from dynamic 18F-FDG-PET/CT for evaluating the risk of clinical events (CEs) in CS. The SUV and Ki myocardial images were generated from 30 dynamic 18F-FDG-PET/CT scans of 21 CS patients. The SUV and Ki images both were rated as positive in 19 scans and negative in 11 scans with the same incidence of CEs which were significantly higher in positive than negative scans [cardiac dysfunction: 78.9% (15/19) vs. 27.2% (3/11); arrhythmic events: 65.5% (10/19) vs. 0% (0/11)]. In 19 positive scans, the three Ki parameters (Ki max, Ki mean and Ki volume) were significantly higher in scans for patients with arrhythmic events than in those without. Logistic regression analysis showed that the Ki volume alone was significantly associated with the risk of arrhythmic events. Our study suggests that Ki images may add value to SUV images for evaluating the risk of CEs in CS patients.

Entities:  

Year:  2021        PMID: 33526847      PMCID: PMC7851386          DOI: 10.1038/s41598-021-82217-0

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  41 in total

1.  Reevaluation of the standardized uptake value for FDG: variations with body weight and methods for correction.

Authors:  Y Sugawara; K R Zasadny; A W Neuhoff; R L Wahl
Journal:  Radiology       Date:  1999-11       Impact factor: 11.105

Review 2.  Integrated PET/CT: current applications and future directions.

Authors:  Gustav K von Schulthess; Hans C Steinert; Thomas F Hany
Journal:  Radiology       Date:  2006-02       Impact factor: 11.105

3.  Comparative evaluation of 18F-FDG PET and 67Ga scintigraphy in patients with sarcoidosis.

Authors:  Yoshihiro Nishiyama; Yuka Yamamoto; Kotaro Fukunaga; Hiroyuki Takinami; Yasuyoshi Iwado; Katashi Satoh; Motoomi Ohkawa
Journal:  J Nucl Med       Date:  2006-10       Impact factor: 10.057

4.  Quantitative interpretation of FDG PET/CT with myocardial perfusion imaging increases diagnostic information in the evaluation of cardiac sarcoidosis.

Authors:  Azadeh Ahmadian; Ashley Brogan; Jeffrey Berman; Aaron L Sverdlov; Gustavo Mercier; Michael Mazzini; Praveen Govender; Frederick L Ruberg; Edward J Miller
Journal:  J Nucl Cardiol       Date:  2014-05-31       Impact factor: 5.952

5.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

6.  Comparison between new-generation SiPM-based and conventional PMT-based TOF-PET/CT.

Authors:  Kei Wagatsuma; Kenta Miwa; Muneyuki Sakata; Keiichi Oda; Haruka Ono; Masashi Kameyama; Jun Toyohara; Kenji Ishii
Journal:  Phys Med       Date:  2017-10-25       Impact factor: 2.685

7.  Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study.

Authors:  Riina Kandolin; Jukka Lehtonen; Juhani Airaksinen; Tapani Vihinen; Heikki Miettinen; Kari Ylitalo; Kari Kaikkonen; Suvi Tuohinen; Petri Haataja; Tuomas Kerola; Jorma Kokkonen; Markus Pelkonen; Päivi Pietilä-Effati; Seppo Utrianen; Markku Kupari
Journal:  Circulation       Date:  2014-12-19       Impact factor: 29.690

8.  Diagnostic value of quantitative assessment of cardiac 18F-fluoro-2-deoxyglucose uptake in suspected cardiac sarcoidosis.

Authors:  Adrien Lebasnier; Damien Legallois; Boris Bienvenu; Emmanuel Bergot; Cédric Desmonts; Gérard Zalcman; Denis Agostini; Alain Manrique
Journal:  Ann Nucl Med       Date:  2018-03-20       Impact factor: 2.668

Review 9.  The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience.

Authors:  George Youssef; Eugene Leung; Ilias Mylonas; Pablo Nery; Kathryn Williams; Gerald Wisenberg; Karen Y Gulenchyn; Robert A Dekemp; Jean Dasilva; David Birnie; George A Wells; Rob S B Beanlands
Journal:  J Nucl Med       Date:  2012-01-06       Impact factor: 10.057

10.  Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing.

Authors:  Davendra Mehta; Steven A Lubitz; Zev Frankel; Juan P Wisnivesky; Andrew J Einstein; Martin Goldman; Josef Machac; Alvin Teirstein
Journal:  Chest       Date:  2008-03-13       Impact factor: 9.410

View more
  2 in total

1.  Short-time-window Patlak imaging using a population-based arterial input function and optimized Bayesian penalized likelihood reconstruction: a feasibility study.

Authors:  Takato Tanaka; Masatoyo Nakajo; Hirofumi Kawakami; Eriko Motomura; Tomofumi Fujisaka; Satoko Ojima; Yasumasa Saigo; Takashi Yoshiura
Journal:  EJNMMI Res       Date:  2022-09-08       Impact factor: 3.434

2.  Priority of PET-CT vs CT Thorax for EBUS-TBNA 22G vs 19G: Mesothorax Lymphadenopathy.

Authors:  Paul Zarogoulidis; Haidong Huang; Zhenli Hu; Ning Wu; Jiannan Wang; Dimitris Petridis; Kosmas Tsakiridis; Dimitris Matthaios; Christoforos Kosmidis; Wolfgang Hohenforst-Schmidt; Christos Tolis; Ioannis Boukovinas; Nikolaos Courcoutsakis; George Nikolaidis; Chrysanthi Sardeli; Chong Bai; Chrysanthi Karapantzou
Journal:  J Cancer       Date:  2021-08-05       Impact factor: 4.207

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.